You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Details for New Drug Application (NDA): 018227


✉ Email this page to a colleague

« Back to Dashboard


NDA 018227 describes AMIDATE, which is a drug marketed by Hospira and is included in one NDA. It is available from three suppliers. Additional details are available on the AMIDATE profile page.

The generic ingredient in AMIDATE is etomidate. There are six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the etomidate profile page.
Summary for 018227
Tradename:AMIDATE
Applicant:Hospira
Ingredient:etomidate
Patents:0
Pharmacology for NDA: 018227
Physiological EffectGeneral Anesthesia
Medical Subject Heading (MeSH) Categories for 018227
Suppliers and Packaging for NDA: 018227
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
AMIDATE etomidate INJECTABLE;INJECTION 018227 NDA Henry Schein, Inc. 0404-9811 0404-9811-10 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9811-10) / 10 mL in 1 VIAL, SINGLE-DOSE
AMIDATE etomidate INJECTABLE;INJECTION 018227 NDA Hospira, Inc. 0409-6695 0409-6695-01 10 VIAL, SINGLE-DOSE in 1 TRAY (0409-6695-01) / 10 mL in 1 VIAL, SINGLE-DOSE (0409-6695-11)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength2MG/ML
Approval Date:Sep 7, 1982TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.